UNH vs BMY
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BMY |
|---|---|---|
| Price | $376.59 | $62.86 |
| Market cap | $338.03B | $128.41B |
| P/E ratio | 24.2 | 13.8 |
| ROE | 14.15% | 46.60% |
| Profit margin | 3.14% | 18.87% |
| Revenue growth | 0.40% | 5.70% |
| Dividend yield | 2.46% | 4.01% |
| Beta | 0.62 | 0.23 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BMY in plain English
- UNH is the bigger company — about 2.6× the market cap of BMY.
- BMY is cheaper on earnings (P/E 13.8 vs 24.2).
- BMY earns a higher return on equity (47% vs 14%).
- BMY is growing revenue faster (6% vs 0%).
- BMY has the higher dividend yield (4.01% vs 2.46%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.